TY - JOUR
T1 - The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression
AU - Ma, Biao
AU - Cheng, Hongcheng
AU - Mu, Chenglong
AU - Geng, Guangfeng
AU - Zhao, Tian
AU - Luo, Qian
AU - Ma, Kaili
AU - Chang, Rui
AU - Liu, Qiangqiang
AU - Gao, Ruize
AU - Nie, Junli
AU - Xie, Jiaying
AU - Han, Jinxue
AU - Chen, Linbo
AU - Ma, Gui
AU - Zhu, Yushan
AU - Chen, Quan
N1 - Funding Information:
The authors thank Dr. Jintang Dong from Nankai University for providing the mouse spontaneous breast cancer samples and Dr. Jie Li for proofreading of this manuscript. This work was supported by the National Natural Sciences Foundation of China (91754114, 31701235 and 91849201), Key project of Frontier Science of Chinese Academy of Sciences (QYZDJSSW-SMC004), Fund for Strategic Pilot Technology Chinese Academy of Sciences (XDPB1002), 111 Project from the Ministry of Education and the State Administration of Foreign Experts Affairs of the People’s Republic of China (B08011) and the China Postdoctoral Science Foundation (2017M610159).
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12/1
Y1 - 2019/12/1
N2 - The interactions between tumor cells with their microenvironments, including hypoxia, acidosis and immune cells, lead to the tumor heterogeneity which promotes tumor progression. Here, we show that SIAH2-NRF1 axis remodels tumor microenvironment through regulating tumor mitochondrial function, tumor-associated macrophages (TAMs) polarization and cell death for tumor maintenance and progression. Mechanistically, low mitochondrial gene expression in breast cancers is associated with a poor clinical outcome. The hypoxia-activated E3 ligase SIAH2 spatially downregulates nuclear-encoded mitochondrial gene expression including pyruvate dehydrogenase beta via degrading NRF1 (Nuclear Respiratory Factor 1) through ubiquitination on lysine 230, resulting in enhanced Warburg effect, metabolic reprogramming and pro-tumor immune response. Dampening NRF1 degradation under hypoxia not only impairs the polarization of TAMs, but also promotes tumor cells to become more susceptible to apoptosis in a FADD-dependent fashion, resulting in secondary necrosis due to the impairment of efferocytosis. These data represent that inhibition of NRF1 degradation is a potential therapeutic strategy against cancer.
AB - The interactions between tumor cells with their microenvironments, including hypoxia, acidosis and immune cells, lead to the tumor heterogeneity which promotes tumor progression. Here, we show that SIAH2-NRF1 axis remodels tumor microenvironment through regulating tumor mitochondrial function, tumor-associated macrophages (TAMs) polarization and cell death for tumor maintenance and progression. Mechanistically, low mitochondrial gene expression in breast cancers is associated with a poor clinical outcome. The hypoxia-activated E3 ligase SIAH2 spatially downregulates nuclear-encoded mitochondrial gene expression including pyruvate dehydrogenase beta via degrading NRF1 (Nuclear Respiratory Factor 1) through ubiquitination on lysine 230, resulting in enhanced Warburg effect, metabolic reprogramming and pro-tumor immune response. Dampening NRF1 degradation under hypoxia not only impairs the polarization of TAMs, but also promotes tumor cells to become more susceptible to apoptosis in a FADD-dependent fashion, resulting in secondary necrosis due to the impairment of efferocytosis. These data represent that inhibition of NRF1 degradation is a potential therapeutic strategy against cancer.
UR - http://www.scopus.com/inward/record.url?scp=85062397835&partnerID=8YFLogxK
U2 - 10.1038/s41467-019-08618-y
DO - 10.1038/s41467-019-08618-y
M3 - Article
C2 - 30833558
AN - SCOPUS:85062397835
SN - 2041-1723
VL - 10
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 1034
ER -